BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4088917)

  • 21. Cellular and membrane properties of alpha and beta thalassemic erythrocytes are different: implication for differences in clinical manifestations.
    Schrier SL; Rachmilewitz E; Mohandas N
    Blood; 1989 Nov; 74(6):2194-202. PubMed ID: 2804358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in erythrocyte rigidity and neonatal relative viscosity during the adaptation of the newborn to extrauterine life. Observations on term and premature newborns].
    Uberos-Fernández J; Muñoz-Hoyos A; Molina-Carbayo A; Ruiz-Cosano C; Valenzuela-Ruiz A; Molina-Font JA
    An Esp Pediatr; 1996 Mar; 44(3):262-6. PubMed ID: 8830603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous platelet aggregation in thalassemic children and adolescents.
    Laosombat V; Wongchanchailert M; Kenpitak K; Wisitpongpon C
    Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():42-6. PubMed ID: 1298992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red blood cell deformability in diabetes mellitus: effect of phytomenadione.
    Sabo A; Jakovljević V; Stanulović M; Lepsanović L; Pejin D
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):1-5. PubMed ID: 8444511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red blood cell vesicles in thalassemia.
    Lamchiagdhase P; Nitipongwanich R; Rattanapong C; Noulsri E; Lerdwana S; Pattanapanyasat K
    J Med Assoc Thai; 2004 Mar; 87(3):233-8. PubMed ID: 15117038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical management of beta-thalassemia.
    Graziano J; Piomelli S
    Tex Rep Biol Med; 1980-1981; 40():355-64. PubMed ID: 7034276
    [No Abstract]   [Full Text] [Related]  

  • 27. New evidence of red blood cell rheological disorders in beta-thalassaemia minor.
    Pérez S; Milani A; Acosta L; Rasia RJ
    Clin Hemorheol Microcirc; 2004; 31(2):89-96. PubMed ID: 15310943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemorheologic effects of ioxaglate: a contribution to an interpretation of the effect of hyperosmolar roentgen contrast media on the fluidity of erythrocytes].
    Schmid-Schönbein H; Teitel P; Tietz G; Ozlen A
    Radiologe; 1984 Oct; 24(10):478-87. PubMed ID: 6505220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemorheologic profile in systemic sclerosis: role of NOS3 -786T > C and 894G >T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease.
    Fatini C; Mannini L; Sticchi E; Rogai V; Guiducci S; Conforti ML; Cinelli M; Pignone AM; Bolli P; Abbate R; Cerinic MM
    Arthritis Rheum; 2006 Jul; 54(7):2263-70. PubMed ID: 16802365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of splenectomy on patients undergoing liver transplantation].
    Wang WL; Gao L; Liang TB; Yao MY; Lu AW; Zheng SS
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1240-3. PubMed ID: 16796881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in peripheral arterial and venous hemorheologic parameters.
    Mokken FC; van der Waart FJ; Henny CP; Goedhart PT; Gelb AW
    Ann Hematol; 1996 Sep; 73(3):135-7. PubMed ID: 8841101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of iron overload in thalassemia.
    Piomelli S; Graziano J
    Birth Defects Orig Artic Ser; 1982; 18(7):339-46. PubMed ID: 7159742
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched-related allogeneic stem cell transplantation.
    Mathews V; George B; Lakshmi KM; Viswabandya A; John JM; Sitaram U; Daniel D; Chandy M; Srivastava A
    Pediatr Transplant; 2009 Mar; 13(2):171-6. PubMed ID: 18482210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperviscosity as a possible risk factor for cerebral ischemic complications in atrial fibrillation patients.
    Cecchi E; Marcucci R; Poli D; Antonucci E; Abbate R; Gensini GF; Prisco D; Mannini L
    Am J Cardiol; 2006 Jun; 97(12):1745-8. PubMed ID: 16765126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behavior of blood folate in children with thalassemia major under transfusion therapy and in thalassemia trait].
    Castagna PC; Fedeli F; Fusco AM; Montani L; Radaelli F; Tartara R
    Acta Vitaminol Enzymol; 1984; 6(3):183-8. PubMed ID: 6524578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemorheologic changes in ankylosing spondylitis].
    Ernst E; Roloff C; Magyarosy J; Drexel H
    Z Rheumatol; 1984; 43(4):190-2. PubMed ID: 6495894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splenectomy changes the pattern of cytokine production in beta-thalassemic patients.
    Moshtaghi-Kashanian GR; Gholamhoseinian A; Hoseinimoghadam A; Rajabalian S
    Cytokine; 2006 Sep; 35(5-6):253-7. PubMed ID: 17081768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin.
    Bozzo J; Hernández MR; Ordinas A
    Cardiovasc Res; 1995 Nov; 30(5):725-30. PubMed ID: 8595619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemorheologic and clinical changes in ankylosing spondylitis during hyperthermia].
    Matrai A; Ernst E
    Acta Med Austriaca; 1991; 18(5):120-4. PubMed ID: 1796724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Blood preservation. Bacteriological, immunohematological, hematological and hemorrheological studies].
    Rasia RJ; Valverde J; García Rosasco M
    Sangre (Barc); 1998 Feb; 43(1):71-6. PubMed ID: 9577185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.